Inflammation and prevention of epileptogenesis

Neuroscience Letters

Volumn 497, Issue 3, 2011, Pages 223-230

  Ravizza, Teresa ^a   Balosso, Silvia ^a   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Anti inflammatory; Brain development; COX 2; Cytokines; Epilepsy; Interleukin; Lipopolysaccharide; Toll like receptor

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CYCLOSPORIN A; CYTOKINE; ERYTHROPOIETIN; GLUTAMATE RECEPTOR; IBUPROFEN; INDOMETACIN; ION CHANNEL; MEFENAMIC ACID; NAPROXEN; NIMESULIDE; PARACETAMOL; PARECOXIB; RAPAMYCIN; RESVERATROL; ROFECOXIB; TACROLIMUS; VERY LATE ACTIVATION ANTIGEN 4;

APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN; COGNITION; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GENETIC TRANSCRIPTION; GLIA CELL; HIPPOCAMPAL CA1 REGION; HUMAN; INFLAMMATION; LEUKOCYTE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; STIMULUS GENERALIZATION; TRANSCRIPTION INITIATION; TRAUMATIC BRAIN INJURY; UPREGULATION;

ANIMALS; ANTICONVULSANTS; BRAIN; ENCEPHALITIS; EPILEPSY; HUMANS;

EID: 79957807767     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.02.040     Document Type: Review

References (118)

1. Abbott J.N. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol. Neurobiol. 2000, 20:131-147.
2. Akarsu E.S., Ozdayi S., Algan E., Ulupinar F. The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction. Epilepsy Res. 2006, 71:181-187.
3. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
4. Annegers J.F., Hauser W.A., Beghi E., Nicolosi A., Kurland L.T. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988, 38:1407-1410.
5. Auvin S., Mazarati A., Shin D. Inflammation enhances epileptogenesis in immature rat brain. Neurobiol. Dis. 2010, 40:303-310.
6. Auvin S., Porta N., Nehlig A., Lecointe C., Vallee L., Bordet R. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res. 2009, 86:124-130.
7. Auvin S., Shin D., Mazarati A., Sankar R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010, 51(Suppl. 3):34-38.
8. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
9. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I.L., De Simoni M.G., Vezzani A. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol. 2005, 57:804-812.
10. Balosso S., Ravizza T., Pierucci M., Calcagno E., Invernizzi R.W., Di Giovanni G., Esposito E., Vezzani A. Molecular and functional interactions between TNF-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
11. Bartfai T., Sanchez-Alavez M., Andell-Jonsson S., Schultzberg M., Vezzani A., Danielsson E., Conti B. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann. N. Y. Acad. Sci. 2007, 1113:173-177.
12. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
13. Berg A.T., Darefsky A.S., Holford T.R., Shinnar S. Seizures with fever after unprovoked seizures: an analysis in children followed from the time of a first febrile seizure. Epilepsia 1998, 39:77-80.
14. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., Zimmer J. Modulator effects of interleukin 1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 2005, 25:6734-6744.
15. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
16. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10061-10065.
17. Casamenti F., Prosperi C., Scali C., Giovannelli L., Colivicchi M.A., Faussone-Pellegrini M.S., Pepeu G. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience 1999, 91:831-842.
18. Chen C., Bazan N.G. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat. 2005, 77:65-76.
19. Choi J., Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J. 2008, 49:1-18.
20. Chrzaszcz M., Venkatesan C., Dragisic T., Watterson D.M., Wainwright M.S. Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures. J. Neurotrauma 2010, 27:1283-1295.
21. Chu K., Jung K.H., Lee S.T., Kim J.H., Kang K.M., Kim H.K., Lim J.S., Park H.K., Kim M., Lee S.K., Roh J.K. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008, 49:1723-1732.
22. Cole-Edwards K.K., Bazan N.G. Lipid signaling in experimental epilepsy. Neurochem. Res. 2005, 30:847-853.
23. David Y., Cacheaux L.P., Ivens S., Lapilover E., Heinemann U., Kaufer D., Friedman A. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?. J. Neurosci. 2009, 29:10588-10599.
24. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:6368-6371.
25. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12:2623-2633.
26. Dhir A., Naidu P.S., Kulkarni S.K. Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice. Clin. Exp. Pharmacol. Physiol. 2005, 32:574-584.
27. Dhir A., Naidu P.S., Kulkarni S.K. Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice. Fundam. Clin. Pharmacol. 2006, 20:255-261.
28. Dhir A., Naidu P.S., Kulkarni S.K. Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure 2007, 16:691-697.
29. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., Lallement G., Dorandeu F. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
30. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
31. Dmowska M., Cybulska R., Schoenborn R., Piersiak T., Jaworska-Adamu J., Gawron A. Behavioural and histological effects of preconditioning with lipopolysaccharide in epileptic rats. Neurochem. Res. 2010, 35:262-272.
32. Dubé C.M., Brewster A.L., Richichi C., Zha Q., Baram T.Z. Fever, febrile seizures and epilepsy. Trends Neurosci. 2007, 30:490-496.
33. Fabene P.F., Mora G.N., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14:1377-1383.
34. Fellin T., Gomez-Gonzalo M., Gobbo S., Carmignoto G., Haydon P.G. Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices. J. Neurosci. 2006, 26:9312-9322.
35. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci. 2008, 28:6904-6913.
36. Galic M.A., Riazi K., Henderson A.K., Tsutsui S., Pittman Q.J. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol. Dis. 2009, 36:343-351.
37. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 1988, 8:2485-2490.
38. Godukhin O.V., Levin S.G., Parnyshkova E.Y. The effects of interleukin-10 on the development of epileptiform activity in the hippocampus induced by transient hypoxia, bicuculline, and electrical kindling. Neurosci. Behav. Physiol. 2009, 39:625-631.
39. Gorter J.A., van Vliet E.A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F.H., Wadman W.J. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 2006, 26:11083-11110.
40. Harré E.M., Galic M.A., Mouihate A., Noorbakhsh F., Pittman Q.J. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-d-aspartate receptor subunit mRNA in the adult rat brain. Eur. J. Neurosci. 2008, 27:644-653.
41. Hermann G.E., Rogers R.C., Bresnahan J.C., Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 2001, 8:590-599.
42. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994, 13:487-494.
43. Holtman L., van Vliet E.A., van Schaik R., Queiroz C.M., Aronica E., Gorter J.A. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res. 2009, 84:56-66.
44. Homayoun H., Khavandgar S., Dehpour A.R. Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system. Brain Res. 2002, 939:1-10.
45. Hu S., Sheng W.S., Ehrlich L.C., Peterson P.K., Chao C.C. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000, 7:153-159.
46. Huang T.L., O'Banion M.K. Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes. J. Neurochem. 1998, 71:1436-1442.
47. Jung K.H., Chu K., Lee S.T., Kim J., Sinn D.I., Kim J.M., Park D.K., Lee J.J., Kim S.U., Kim M., Lee S.K., Roh J.K. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis. 2006, 23:237-246.
48. Kharatishvili I., Pitkanen A. Association of the severity of cortical damage with the occurrence of spontaneous seizures and hyperexcitability in an animal model of posttraumatic epilepsy. Epilepsy Res. 2010, 90:47-59.
49. Kim H.J., Chung J.I., Lee S.H., Jung Y.S., Moon C.H., Baik E.J. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res. 2008, 1193:153-161.
50. Kirkman N.J., Libbey J.E., Wilcox K.S., White H.S., Fujinami R.S. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 2010, 51:454-464.
51. Kulkarni S.K., Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc.) 2009, 45:135-154.
52. Kunz T., Oliw E.H. Nimesulide aggravates kainic acid-induced seizures in the rat. Pharmacol. Toxicol. 2001, 88:271-276.
53. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 1999, 98:77-88.
54. Leonoudakis D., Braithwaite S.P., Beattie M.S., Beattie E.C. TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?. Neuron Glia Biol. 2004, 1:263-273.
55. Libbey J.E., Kirkman N.J., Smith M.C., Tanaka T., Wilcox K.S., White H.S., Fujinami R.S. Seizures following picornavirus infection. Epilepsia 2008, 49:1066-1074.
56. Linker R., Gold R., Luhder F. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit. Rev. Immunol. 2009, 29:43-68.
57. Lloyd E., Somera-Molina K., Van Eldik L.J., Watterson D.M., Wainwright M.S. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J. Neuroinflammation 2008, 5:28.
58. Lohman R.J., O'Brien T.J., Cocks T.M. Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis. Neurobiol. Dis. 2008, 30:84-93.
59. Lucas S.M., Rothwell N.J., Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 2006, 147(Suppl. 1):S232-S240.
60. Lukasiuk K., Pitkanen A. Large-scale analysis of gene expression in epilepsy research: is synthesis already possible?. Neurochem. Res. 2004, 29:1169-1178.
61. Lukasiuk K., Sliwa A. FK506 aggravates development and severity of disease in the rat model of temporal lobe epilepsy. The 8th European Congress on Epileptology, Berlin, Abstract Number Y175 2008, p. 102.
62. Majores M., Eils J., Wiestler O.D., Becker A.J. Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models. Epilepsy Res. 2004, 60:173-178.
63. Marchi N., Fan Q., Ghosh C., Fazio V., Bertolini F., Betto G., Batra A., Carlton E., Najm I., Granata T., Janigro D. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis. 2009, 33:171-181.
64. Marcon J., Gagliardi B., Balosso S., Maroso M., Noé F., Morin M., Lerner-Natoli M., Vezzani A., Ravizza T. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol. Dis. 2009, 34:121-132.
65. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
66. Mirrione M.M., Konomos D.K., Gravanis I., Dewey S.L., Aguzzi A., Heppner F.L., Tsirka S.E. Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. Neurobiol. Dis. 2010, 39:85-97.
67. Moia L.J., Matsui H., de Barros G.A., Tomizawa K., Miyamoto K., Kuwata Y., Tokuda M., Itano T., Hatase O. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Brain Res. 1994, 648:337-341.
68. Neal H., Keane P.E. Electrically and chemically induced spindling and slow waves in the encephale isole rat: a possible role for dopamine in the regulation of electrocortical activity. Electroencephalogr. Clin. Neurophysiol. 1980, 48:318-326.
69. Oby E., Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774.
70. Oliveira M.S., Furian A.F., Royes L.F., Fighera M.R., Fiorenza N.G., Castelli M., Machado P., Bohrer D., Veiga M., Ferreira J., Cavalheiro E.A., Mello C.F. Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res. 2008, 79:14-21.
71. Pitkanen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia 2010, 51(Suppl. 3):2-17.
72. Pitkanen A., Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002, 1:173-181.
73. Polascheck N., Bankstahl M., Loscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol. 2010, 224:219-233.
74. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 1997, 72:137-141.
75. Rao R.S., Medhi B., Saikia U.N., Arora S.K., Toor J.S., Khanduja K.L., Pandhi P. Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat. Eur. Neuropsychopharmacol. 2008, 18:760-767.
76. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
77. Ravizza T., Noé F., Zardoni D., Vaghi V., Sifringer M., Vezzani A. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis. 2008, 31:327-333.
78. Riazi K., Galic M.A., Kuzmiski J.B., Ho W., Sharkey K.A., Pittman Q.J. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17151-17156.
79. Riazi K., Galic M.A., Pittman Q.J. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010, 89:34-42.
80. Sayyah M., Javad-Pour M., Ghazi-Khansari M. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience 2003, 122:1073-1080.
81. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:405-410.
82. Shandra A.A., Godlevsky L.S., Vastyanov R.S., Oleinik A.A., Konovalenko V.L., Rapoport E.N., Korobka N.N. The role of TNF-alpha in amygdala kindled rats. Neurosci. Res. 2002, 42:147-153.
83. Singh A., Kumar G., Naidu P.S., Kulkarni S.K. Protective effect of FK506 (tacrolimus) in pentylenetetrazol-induced kindling in mice. Pharmacol. Biochem. Behav. 2003, 75:853-860.
84. Somera-Molina K.C., Nair S., Van Eldik L.J., Watterson D.M., Wainwright M.S. Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res. 2009, 1282:162-172.
85. Somera-Molina K.C., Robin B., Somera C.A., Anderson C., Stine C., Koh S., Behanna H.A., Van Eldik L.J., Watterson D.M., Wainwright M.S. Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 2007, 48:1785-1800.
86. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
87. Suzuki K., Omura S., Ohashi Y., Kawai M., Iwata Y., Tani K., Sekine Y., Takei N., Mori N. FK506 facilitates chemical kindling induced by pentylenetetrazole in rats. Epilepsy Res. 2001, 46:279-282.
88. Takemiya T., Suzuki K., Sugiura H., Yasuda S., Yamagata K., Kawakami Y., Maru E. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat. 2003, 71:205-216.
89. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
90. Tanaka S., Nakamura T., Sumitani K., Takahashi F., Konishi R., Itano T., Miyamoto O. Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model. Neurosci. Res. 2009, 65:79-87.
91. Temkin N.R. Preventing and treating posttraumatic seizures: the human experience. Epilepsia 2009, 50(Suppl. 2):10-13.
92. Tian G.F., Azmi H., Takano T., Xu Q., Peng W., Lin J., Oberheim N., Lou N., Wang X., Zielke H.R., Kang J., Nedergaard M. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
93. Tu B., Bazan N.G. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol. 2003, 179:167-175.
94. Turrin N.P., Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 2004, 16:321-334.
95. Vergnolle N., Wallace J.L., Bunnett N.W., Hollenberg M.D. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci. 2001, 22:146-152.
96. Vezzani A., Balosso S., Maroso M., Zardoni D., Noé F., Ravizza T. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr. Opin. Investig. Drugs 2010, 11:43-50.
97. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
98. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19:5054-5065.
99. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
100. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
101. Vezzani A., Janigro D. Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers. Epilepsy Curr. 2009, 9:118-121.
102. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
103. Viviani B., Gardoni F., Bartesaghi S., Corsini E., Facchi A., Galli C.L., Di Luca M., Marinovich M. Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J. Biol. Chem. 2006, 281:30212-30222.
104. Viviani B., Gardoni F., Marinovich M. Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol. 2007, 82:247-263.
105. Voutsinos-Porche B., Koning E., Kaplan H., Ferrandon A., Guenounou M., Nehlig A., Motte J. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 2004, 17:385-402.
106. Wallenstein M.C. Attenuation of epileptogenesis by nonsteroidal anti-inflammatory drugs in the rat. Neuropharmacology 1991, 30:657-663.
107. Weichhart T., Saemann M.D. The multiple facets of mTOR in immunity. Trends Immunol. 2009, 30:218-226.
108. Whitney N.P., Eidem T.M., Peng H., Huang Y., Zheng J.C. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 2009, 108:1343-1359.
109. Williams A.J., Berti R., Yao C., Price R.A., Velarde L.C., Koplovitz I., Schultz S.M., Tortella F.C., Dave J.R. Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci. Lett. 2003, 349:147-150.
110. Wu H.M., Liang Y.C., Chen S.H., Huang C.C., Tsai J.J., Hsieh C.L., Hsu K.S. Valacyclovir treatment ameliorates the persistently increased pentylenetetrazol-induced seizure susceptibility in mice with herpes simplex virus type 1 infection. Exp. Neurol. 2004, 189:66-77.
111. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res. 2009, 34:1393-1400.
112. Ye Z.C., Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 1996, 7:2181-2185.
113. Yu Z., Cheng G., Wen X., Wu G.D., Lee W.T., Pleasure D. Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaB-dependent mechanism. Neurobiol. Dis. 2002, 11:199-213.
114. Yuhas Y., Shulman L., Weizman A., Kaminsky E., Vanichkin A., Ashkenazi S. Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect. Immun. 1999, 67:1455-1460.
115. Yuhas Y., Weizman A., Ashkenazi S. Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures. Infect Immun. 2003, 71:2288-2291.
116. Zardoni D., Maroso M., Balosso S., Ravizza T., Noé F., Vezzani A. The role of T- and B-cells in seizures and epilepsy. 9th European Congress on Epileptology Rhodes 2010.
117. Zeng L.H., Rensing N.R., Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci. 2009, 29:6964-6972.
118. Zou J.Y., Crews F.T. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005, 1034:11-24.